Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.

Mori, Nobuaki

Re: Efficacy of favipiravir in adults with mild COVID-19 by Bosaeed et al.

Mori, Nobuaki.

Mori N; Department of General Internal Medicine and Infectious Diseases, National Hospital Organization, Tokyo Medical Center, 2-5-1 Higashigaoka, Meguro Ward, Tokyo 152-8902, Japan. Electronic address: nobuaki.m@icloud.com.

Clin Microbiol Infect ; 28(10): 1399, 2022 10.

Article in English | MEDLINE | ID: covidwho-2104605

Subject(s)

COVID-19 Drug Treatment; Adult; Amides/therapeutic use; Antiviral Agents/therapeutic use; Humans; Pyrazines/therapeutic use; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Prognostic study Limits: Adult / Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google